Safety comparison of weekly docetaxel vs CMF as adjuvant chemotherapy for elderly breast cancer patients (The ELDA trial)

ANNALS OF ONCOLOGY(2007)

Cited 0|Views36
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined